SetPoint Medical
Valencia, US · 125 employees on LinkedIn · 11 known investors
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs. The company applies this "neuroimmune modulation" approach to autoimmune disease care.
Founders & leadership
MS
Murthy SimhambhatlaCEO
DC
David ChernoffChief Medical Officer (MD)
YL
Yaakov LevinePhD
RS
Rohan SethExecutive
Board
BW
Blake WuBoard director
JM
Juan-Pablo MasBoard director
ZS
Zack ScottBoard director
SJ
Steven J WinickBoard director
HP
Hank PlainBoard director
AW
Allan WillBoard director
Investors · 11
Ally Bridge Group✓ verifiedNew York
New Enterprise Associates (NEA)✓ verifiedMenlo Park · $200K – $40Mvia Blake Wu · board
Norwest Venture Partners✓ verifiedMenlo Park · $10M – $30M
Topspin Partners✓ verifiedRoslyn Heights · $10M – $50M
Catalio Capital Management, LPNew York
Citta CapitalPalo Altovia Jim Mao · inferred
Lightstone VenturesPortola Valley
Runway Growth CapitalMenlo Park · $10M – $150M
ShangBay Capital LLCPalo Alto
Action Potential Venture Capital Ltd.reportedScotts Valleyvia Juan-Pablo Mas · board
Cadence Healthcare VenturesreportedHayward
Reported raises · per SEC filings
Form D private placements$290.8M disclosed across 5 rounds · 2015–2025
▶$115.5MraisedOct 2025 · 24 investors · Other Health CareRule 506(b)
▶$115.5MraisedOct 2025 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David ChernoffExecutive Officer
- Murthy SimhambhatlaExecutive Officer, Director
- Zack ScottDirector
- Allan WillDirector
- Steven J WinickDirector
- Rohan SethExecutive Officer
- Tyler BinneyDirector
- Kevin ReillyDirector
- Hank PlainDirector
- Blake WuDirector
- Josh MakowerDirector
- Juan-Pablo MasDirector
- Offering amount
- $115.5M
- Amount sold
- $115.5M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$80MraisedFeb 2025 · 21 investors · Other Health CareRule 506(b)
▶$80MraisedFeb 2025 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Blake WuDirector
- Murthy SimhambhatlaExecutive Officer, Director
- David ChernoffExecutive Officer
- Juan-Pablo MasDirector
- Rohan SethExecutive Officer
- Zack ScottDirector
- Steven J WinickDirector
- Allan WillDirector
- Hank PlainDirector
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$64.4MraisedFeb 2021 · 26 investors · Other Health CareRule 506(b)
▶$64.4MraisedFeb 2021 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Josh MakowerDirector
- Murthy SimhambhatlaExecutive Officer, Director
- Alan WillDirector
- Hank PlainDirector
- Juan-Pablo MasDirector
- Colin MorrisonDirector
- Steven J. WinickDirector
- William DaiDirector
- Offering amount
- $64.4M
- Amount sold
- $64.4M
- Minimum investment
- $1
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.7MraisedSep 2019 · 8 investors · Other Health CareRule 506(b)
▶$15.7MraisedSep 2019 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joe BillerDirector
- Steven J. WinickDirector
- Allan WillDirector
- Hank PlainDirector
- Juan-Pablo MasDirector
- Josh MakowerDirector
- Murthy SimhambhatlaExecutive Officer, Director
- Offering amount
- $20.5M
- Amount sold
- $15.7M
- Minimum investment
- $1
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.1MraisedSep 2015 · 7 investors · BiotechnologyRule 506(b)
▶$15.1MraisedSep 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hank PlainDirector
- David NeustaedterDirector
- Bill GearyDirector
- Juan-Pablo MasDirector
- Anthony ArnoldExecutive Officer, Director
- Alan WillDirector
- Christopher KasterDirector
- Steven WinickDirector
- Offering amount
- $15.1M
- Amount sold
- $15.1M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Medpagetoday44 shared keywordsMedPage Today publishes medical news, clinical research coverage, meeting reports, and physician-focused opinion across specialties such as cardiology, endocrinology, and pulmonology. It serves healthcare professionals, including physicians and nurses, with breaking medical news and continuing coverage.
Power40 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Companies competing with SetPoint Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does SetPoint Medical do?
- SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs. The company applies this "neuroimmune modulation" approach to autoimmune disease care.
- Who are SetPoint Medical's investors?
- SetPoint Medical's investors include Ally Bridge Group, New Enterprise Associates (NEA), Norwest Venture Partners, Topspin Partners, Catalio Capital Management, LP, Citta Capital, Lightstone Ventures, Runway Growth Capital and 3 more.
- How much funding has SetPoint Medical raised?
- SetPoint Medical has disclosed $290.8M raised across 5 rounds.
- Where is SetPoint Medical headquartered?
- SetPoint Medical is headquartered in Valencia, US.